| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
173,744,000 |
| Market
Cap: |
1.01(B) |
| Last
Volume: |
148,509 |
Avg
Vol: |
0 |
| 52
Week Range: |
$5.88 - $15.45 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 8.3 |
| Insider 3/6 Months : 8.9 |
|
| Guru Rank Number : 607 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focusing on developing the treatment of GI diseases. LINZESS® (linaclotide), Co.'s commercial product, is a product in a class of GI medicines called guanylate cyclase type C agonists and is indicated for adult men and women suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). LINZESS is available to adult men and women suffering from IBS-C or CIC in the U.S. and Mexico and to adult men and women suffering from IBS-C in Japan and China. Co. has partnerships with pharmaceutical companies to support the development and commercialization of linaclotide.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
17,604 |
53,676 |
53,676 |
| Total Buy Value |
$0 |
$160,420 |
$460,539 |
$460,539 |
| Total People Bought |
0 |
2 |
2 |
2 |
| Total Buy Transactions |
0 |
2 |
3 |
3 |
| Total Shares Sold |
226,641 |
507,557 |
529,791 |
1,205,966 |
| Total Sell Value |
$1,459,885 |
$5,741,044 |
$5,974,538 |
$13,645,593 |
| Total People Sold |
6 |
7 |
8 |
11 |
| Total Sell Transactions |
7 |
12 |
16 |
50 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rickard Jason |
SVP, Chief Operating Officer |
• – – |
2023-02-27 |
4 |
S |
$11.41 |
$191,072 |
D/D |
(16,746) |
350,077 |
|
11% |
|
| Mccourt Thomas A |
Chief Executive Officer |
• • – |
2023-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
30,145 |
742,585 |
|
- |
|
| Shetzline Michael |
CMO,SVP,Head-Res&Drug |
• – – |
2023-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
14,663 |
280,908 |
|
- |
|
| Rickard Jason |
SVP, Chief Operating Officer |
• – – |
2023-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
18,087 |
366,823 |
|
- |
|
| Mccourt Thomas A |
Chief Executive Officer |
• • – |
2023-01-05 |
4 |
AS |
$12.07 |
$1,339,311 |
D/D |
(110,962) |
712,440 |
|
-19% |
|
| Mccourt Thomas A |
Chief Executive Officer |
• • – |
2023-01-05 |
4 |
OE |
$11.65 |
$1,292,707 |
D/D |
110,962 |
823,402 |
|
- |
|
| Sarissa Capital Management Lp |
10% Owner |
– – • |
2022-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,244 |
91,985 |
|
- |
|
| Rickard Jason |
SVP, Chief Operating Officer |
• – – |
2022-12-14 |
4 |
S |
$12.39 |
$334,530 |
D/D |
(27,000) |
348,736 |
|
16% |
|
| Emany Sravan Kumar |
SVP, Chief Financial Officer |
• – – |
2022-11-21 |
4 |
S |
$11.56 |
$76,042 |
D/D |
(6,578) |
78,422 |
|
8% |
|
| Silver Ronald |
Principal Accounting Officer |
• – – |
2022-11-21 |
4 |
S |
$11.56 |
$7,884 |
D/D |
(682) |
104,469 |
|
8% |
|
| Davis Andrew |
SVP, Chief Business Officer |
• – – |
2022-11-21 |
4 |
S |
$11.56 |
$38,553 |
D/D |
(3,335) |
154,213 |
|
8% |
|
| Mccourt Thomas A |
Chief Executive Officer |
• • – |
2022-10-03 |
4 |
AS |
$10.41 |
$196,739 |
D/D |
(18,899) |
712,440 |
|
8% |
|
| Sarissa Capital Management Lp |
10% Owner |
– – • |
2022-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,374 |
90,741 |
|
- |
|
| Mccourt Thomas A |
Chief Executive Officer |
• • – |
2022-09-01 |
4 |
AS |
$10.65 |
$281,650 |
D/D |
(26,446) |
731,339 |
|
7% |
|
| Silver Ronald |
Principal Accounting Officer |
• – – |
2022-08-15 |
4 |
S |
$11.77 |
$23,705 |
D/D |
(2,014) |
105,151 |
|
-2% |
|
| Rickard Jason |
SVP, Chief Operating Officer |
• – – |
2022-08-15 |
4 |
AS |
$11.77 |
$11,699 |
D/D |
(994) |
375,736 |
|
2% |
|
| John Minardo |
Chief Legal Officer |
• – – |
2022-08-15 |
4 |
S |
$11.77 |
$86,274 |
D/D |
(7,330) |
140,435 |
|
-2% |
|
| Currie Mark G |
Director |
– • – |
2022-08-11 |
4 |
S |
$11.78 |
$824,600 |
D/D |
(70,000) |
521,758 |
|
-6% |
|
| Rickard Jason |
SVP, Chief Operating Officer |
• – – |
2022-08-09 |
4 |
S |
$11.75 |
$211,982 |
D/D |
(18,041) |
376,730 |
|
-2% |
|
| Rickard Jason |
SVP, Chief Operating Officer |
• – – |
2022-08-09 |
4 |
OE |
$11.65 |
$210,178 |
D/D |
18,041 |
394,771 |
|
- |
|
| Rickard Jason |
SVP, Chief Operating Officer |
• – – |
2022-08-08 |
4 |
S |
$11.56 |
$342,456 |
D/D |
(29,436) |
376,730 |
|
-2% |
|
| Mccourt Thomas A |
Chief Executive Officer |
• • – |
2022-08-01 |
4 |
AS |
$11.35 |
$263,649 |
D/D |
(23,229) |
757,785 |
|
9% |
|
| Mccourt Thomas A |
Chief Executive Officer |
• • – |
2022-06-30 |
4 |
AS |
$11.58 |
$231,125 |
D/D |
(19,959) |
778,922 |
|
-1% |
|
| Sarissa Capital Management Lp |
10% Owner |
– – • |
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,222 |
89,367 |
|
- |
|
| Kessler Marla L |
Director |
– • – |
2022-06-14 |
4 |
AS |
$11.65 |
$88,657 |
D/D |
(7,610) |
84,148 |
|
-8% |
|
589 Records found
|
|
Page 4 of 24 |
|
|
0.15 (2.51%) 
